Feb 20, 2017 at 08:26 | Source: CNBC-TV18
Idea Cellular | Axis Bank | Kotak Mahindra Bank | Hindustan Unilever | McNally Bharat | Havells | BPCL | GPT Infra | Mangalam Drugs and GSK Pharma are stocks, which are in the news today.
Feb 11, 2017 at 16:58 | Source: PTI
The company said mandatory price reductions experienced in the earlier quarters of the year had adversely impacted growth by 5 percent in the current quarter.
Feb 09, 2017 at 22:10 | Source: CNBC-TV18
Patrick Vallance, President - R&D, GlaxoSmithKline said the company is looking forward to more collaborations and is looking at a number of options to move ahead with its expansion plans.
Jan 19, 2017 at 13:45 | Source: Reuters
Hussain had been seen as a potential contender to take over from Chief Executive Andrew Witty, who steps down at the end of March, but the job went to GSK's consumer health division boss Emma Walmsley.
Nov 08, 2016 at 15:00 | Source: CNBC-TV18
The US market is seeing a shift in market dynamics and several factors lead to drug product pricing and there will be further pricing pressure over the next few years, said GSK Global Chief Executive Andrew Witty.
Nov 04, 2016 at 08:00 | Source: CNBC-TV18
Tata Motors | Biocon | Berger Paints | GSK Pharma | GVK Power | GMR Infrastructure | Parsvnath Developers | Mphasis | Star Ferro | ESAB India | EIH | Coastal Corporation | FACT | Monsanto | TD Power | Chemfab Alkalies and Tube Investments are stocks, which are in the news today.
Oct 27, 2016 at 14:58 | Source: PTI
It had posted net profit of Rs 95.55 crore for the July- September period of the previous fiscal, GSK Pharma said in a BSE filing.
Oct 10, 2016 at 15:48 | Source: CNBC-TV18
Prakash Gaba of prakashgaba.com is of the view that one may hold GlaxoSmithKline Pharmaceuticals.
Sep 26, 2016 at 14:38 | Source: Moneycontrol.com
With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.
Sep 15, 2016 at 19:49 | Source: Moneycontrol.com
Some investors shy away from buying stocks that have high prices. The belief is unfounded.